Brenda Gallie

Q: What Schools Are Affiliated With Brenda Gallie

Brenda Gallie is affiliated with the following schools: Capital Medical University, University of Toronto

Brenda Gallie's AcademicInfluence.com Rankings

Brenda Gallie

Philosophy

#7792

World Rank

#11049

Historical Rank

Logic

#4829

World Rank

#6158

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Why Is Brenda Gallie Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Brenda Louise Gallie is a Canadian ophthalmologist. She is the Head of the Retinoblastoma Program in the Hospital for Sick Children Department of Ophthalmology and Vision Sciences. Early life and education Gallie completed her medical degree at Queen's University at Kingston in 1969. Following this, she completed her residency and fellowship training at the University of Toronto and a second research fellowship in Immunology and Cancer at the Memorial Sloan-Kettering Cancer Center.

(See a Problem?)

Brenda Gallie's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Expression of recessive alleles by chromosomal mechanisms in retinoblastoma (1983) (1954)
Active surveillance of small renal masses: progression patterns of early stage kidney cancer. (2011) (438)
Using expression profiling data to identify human microRNA targets (2007) (424)
Osteosarcoma and retinoblastoma: a shared chromosomal mechanism revealing recessive predisposition. (1985) (408)
Collaborative Ocular Oncology Group report number 1: prospective validation of a multi-gene prognostic assay in uveal melanoma. (2012) (392)
Chemotherapy with focal therapy can cure intraocular retinoblastoma without radiotherapy. (1996) (387)
Genetic origin of mutations predisposing to retinoblastoma. (1985) (344)
pRb controls proliferation, differentiation, and death of skeletal muscle cells and other lineages during embryogenesis. (1996) (326)
Characterisation of retinoblastomas without RB1 mutations: genomic, gene expression, and clinical studies. (2013) (280)
Sensitive and efficient detection of RB1 gene mutations enhances care for families with retinoblastoma. (2003) (278)
Loss of RB1 induces non-proliferative retinoma: increasing genomic instability correlates with progression to retinoblastoma. (2008) (276)
Identification of germline and somatic mutations affecting the retinoblastoma gene. (1988) (272)
Transcriptional repression of the E2-containing promoters EIIaE, c-myc, and RB1 by the product of the RB1 gene. (1992) (272)
One hit, two hits, three hits, more? Genomic changes in the development of retinoblastoma (2007) (241)
Somatic inactivation of genes on chromosome 13 is a common event in retinoblastoma (1983) (238)
The retinoblastoma protein and the cell cycle. (1992) (218)
Direct transcriptional repression by pRB and its reversal by specific cyclins (1995) (203)
Retinoma: spontaneous regression of retinoblastoma or benign manifestation of the mutation? (1982) (198)
Retinoblastoma (1992) (195)
KIF14 is a candidate oncogene in the 1q minimal region of genomic gain in multiple cancers (2005) (182)
Frequency of somatic and germ-line mosaicism in retinoblastoma: implications for genetic counseling. (1998) (180)
Retinoblastoma: Revisiting the model prototype of inherited cancer (2004) (174)
Mutations of the p53 gene do not occur in testis cancer. (1993) (166)
Mutations in the RB1 gene and their effects on transcription (1989) (162)
The retinoblastoma gene family is differentially expressed during embryogenesis (1997) (155)
The genomic landscape of retinoblastoma: a review (2014) (154)
Detection of mosaic RB1 mutations in families with retinoblastoma (2009) (140)
Global Retinoblastoma Presentation and Analysis by National Income Level (2020) (136)
Developmental basis of retinal-specific induction of cancer by RB mutation. (1999) (129)
Ocular involvement in neuroblastoma: prognostic implications. (1984) (127)
Retinoblastoma (2012) (124)
Retinoblastoma: the disease, gene and protein provide critical leads to understand cancer. (2000) (120)
Cumulative Effect of Phosphorylation of pRB on Regulation of E2F Activity (1999) (119)
Expression analysis of 6p22 genomic gain in retinoblastoma (2006) (117)
Intra-arterial Chemotherapy for Retinoblastoma: A Systematic Review. (2016) (116)
Combining cyclosporin with chemotherapy controls intraocular retinoblastoma without requiring radiation. (1996) (115)
Hereditary haemorrhagic telangiectasia: mutation detection, test sensitivity and novel mutations (2006) (115)
KIF14 mRNA expression is a predictor of grade and outcome in breast cancer (2006) (113)
Basal and squamous cell carcinoma of the eyelids and their treatment by radiotherapy. (1984) (112)
International Validation of the American Joint Committee on Cancer's 7th Edition Classification of Uveal Melanoma. (2015) (112)
KIF14 Messenger RNA Expression Is Independently Prognostic for Outcome in Lung Cancer (2007) (108)
Mechanisms of loss of heterozygosity in retinoblastoma. (1992) (107)
A bipartite nuclear localization signal in the retinoblastoma gene product and its importance for biological activity (1993) (107)
Ocular motility changes after subtenon carboplatin chemotherapy for retinoblastoma. (2003) (106)
MYCN protein expression as a predictor of neuroblastoma prognosis. (1997) (104)
Speculations on the roles of RB1 in tissue‐specific differentiation, tumor initiation, and tumor progression (1993) (104)
Genetics and Molecular Diagnostics in Retinoblastoma—An Update (2017) (101)
Cost comparison of molecular versus conventional screening of relatives at risk for retinoblastoma. (1996) (101)
Multidrug resistance protein (MRP) expression in retinoblastoma correlates with the rare failure of chemotherapy despite cyclosporine for reversal of P-glycoprotein. (1997) (99)
Minimal regions of chromosomal imbalance in retinoblastoma detected by comparative genomic hybridization. (2001) (96)
Profiling genomic copy number changes in retinoblastoma beyond loss of RB1 (2007) (93)
Local Recurrence Significantly Increases the Risk of Metastatic Uveal Melanoma. (2016) (91)
Hand-held high-resolution spectral domain optical coherence tomography in retinoblastoma: clinical and morphologic considerations (2012) (89)
Growth of human tumors in immune-deficient scid mice and nude mice. (1989) (87)
Pre-enucleation chemotherapy for eyes severely affected by retinoblastoma masks risk of tumor extension and increases death from metastasis. (2011) (87)
Deletion of RB exons 24 and 25 causes low-penetrance retinoblastoma. (1997) (86)
Heterotransplantation of retinoblastoma into the athymic "nude" mouse. (1977) (80)
A sensitive method for immunocytochemical detection of P-glycoprotein in multidrug-resistant human ovarian carcinoma cell lines. (1988) (80)
Expression patterns of the E2F family of transcription factors during mouse nervous system development (1997) (79)
Tumour induction by the retinoblastoma mutation is independent of N-myc expression (1986) (79)
Development of retinoblastoma in the absence of telomerase activity. (1996) (79)
Common neuroectodermal antigens on human melanoma, neuroblastoma, retinoblastoma, glioblastoma and fetal brain revealed by hybridoma antibodies raised against melanoma cells (1981) (78)
Multidrug-resistant phenotype in retinoblastoma correlates with P-glycoprotein expression. (1991) (78)
Kinesin family member 14: An independent prognostic marker and potential therapeutic target for ovarian cancer (2012) (77)
Significance of retinoma and phthisis bulbi for retinoblastoma. (1982) (76)
Spectrum of gross deletions and insertions in the RB1 gene in patients with retinoblastoma and association with phenotypic expression (2005) (74)
Chemotherapy for retinoblastoma. (2005) (74)
Failure of RB1 to reverse the malignant phenotype of human tumor cell lines. (1992) (73)
Infrequent genomic rearrangement and normal expression of the putative RB1 gene in retinoblastoma tumors (1988) (71)
Screening Children at Risk for Retinoblastoma: Consensus Report from the American Association of Ophthalmic Oncologists and Pathologists. (2018) (71)
Minimal 16q genomic loss implicates cadherin-11 in retinoblastoma. (2004) (70)
Expression patterns of the E2F family of transcription factors during murine epithelial development. (1997) (68)
Patterns of missplicing caused by RB1 gene mutations in patients with retinoblastoma and association with phenotypic expression (2008) (68)
Chemosensitivity and multidrug resistance to antineoplastic drugs in retinoblastoma cell lines. (1989) (67)
Penetration of chemotherapy into vitreous is increased by cryotherapy and cyclosporine in rabbits. (1996) (67)
KIF14 negatively regulates Rap1a–Radil signaling during breast cancer progression (2012) (67)
Regions controlling hyperphosphorylation and conformation of the retinoblastoma gene product are independent of domains required for transcriptional repression. (1992) (65)
The retinoblastoma protein and cell cycle regulation. (1992) (64)
Challenging the global retinoblastoma survival disparity through a collaborative research effort (2010) (61)
Evidence for retinoblastoma protein (RB) dependent and independent IFN-gamma responses: RB coordinately rescues IFN-gamma induction of MHC class II gene transcription in noninducible breast carcinoma cells. (1994) (61)
Periocular topotecan for intraocular retinoblastoma. (2011) (61)
A detailed analysis of chromosomal changes in heritable and non-heritable retinoblastoma (2004) (61)
Multiple karyotypic changes in retinoblastoma tumor cells: presence of normal chromosome No. 13 in most tumors. (1982) (60)
Characterization of the human RB1 promoter and of elements involved in transcriptional regulation. (1994) (57)
Cloning of the esterase D gene: a polymorphic gene probe closely linked to the retinoblastoma locus on chromosome 13. (1986) (57)
Prenatal versus Postnatal Screening for Familial Retinoblastoma. (2016) (56)
Management and outcome of unilateral retinoblastoma. (2009) (55)
Hyperphosphorylation of the retinoblastoma gene product is determined by domains outside the simian virus 40 large-T-antigen-binding regions (1990) (55)
Defining a 0.5-mb region of genomic gain on chromosome 6p22 in bladder cancer by quantitative-multiplex polymerase chain reaction. (2004) (53)
Molecular genetic studies of tumor suppressor gene regions on chromosomes 13 and 17 in colorectal tumors. (1992) (52)
The genetics of retinoblastoma. Relevance to the patient. (1991) (52)
Regulation of p14ARF expression by miR-24: a potential mechanism compromising the p53 response during retinoblastoma development (2012) (51)
Mechanism of oncogenesis in retinoblastoma. (1990) (50)
Cost comparison of predictive genetic testing versus conventional clinical screening for familial adenomatous polyposis (1999) (48)
Unraveling the function of the retinoblastoma gene. (1993) (48)
Cdh11 Acts as a Tumor Suppressor in a Murine Retinoblastoma Model by Facilitating Tumor Cell Death (2010) (47)
Optical Coherence Tomography-Guided Decisions in Retinoblastoma Management. (2017) (46)
Growth kinetics of small renal masses: A prospective analysis from the Renal Cell Carcinoma Consortium of Canada. (2014) (44)
Isochromosome 6p, a unique chromosomal abnormality in retinoblastoma: Verification by standard staining techniques, new densitometric methods, and somatic cell hybridization (2004) (44)
Reproducible growth in tissue culture of retinoblastoma tumor specimens. (1982) (43)
The development of optokinetic nystagmus in strabismic and monocularly enucleated subjects (1991) (42)
Multidrug resistance in pediatric malignancies. (1995) (41)
High expression of KIF14 in retinoblastoma: association with older age at diagnosis. (2007) (41)
Retinoblastoma for Pediatric Ophthalmologists (2018) (40)
Visual prognosis of Coats' disease. (1998) (40)
Molecular cloning and characterization of the mouse RB1 promoter. (1993) (40)
Loss of Rb and Myc activation co-operate to suppress cyclin D1 and contribute to transformation. (1996) (39)
Contrast Letter Thresholds in the Non-affected Eye of Strabismic and Unilateral Eye Enucleated Subjects (1996) (39)
Genomic amplification in retinoblastoma narrowed to 0.6 megabase on chromosome 6p containing a kinesin-like gene, RBKIN. (2002) (38)
Nuclear E-cadherin and VHL immunoreactivity are prognostic indicators of clear-cell renal cell carcinoma (2007) (37)
Multicenter, International Assessment of the Eighth Edition of the American Joint Committee on Cancer Cancer Staging Manual for Conjunctival Melanoma (2019) (37)
Focal therapy in the management of retinoblastoma: when to start and when to stop. (2000) (36)
Retinoblastoma pathway deregulatory mechanisms determine clinical outcome in high-grade serous ovarian carcinoma (2014) (36)
Homogeneously staining region in a retinoblastoma cell line: relevance to tumor initiation and progression. (1981) (36)
Multidrug resistance. Clinical opportunities in diagnosis and circumvention. (1994) (35)
Structured electronic operative reporting: Comparison with dictation in kidney cancer surgery (2012) (35)
Expression of p14ARF, MDM2, and MDM4 in human retinoblastoma. (2008) (34)
Retinoblastoma CSF Metastasis Cured By Multimodality Chemotherapy Without Radiation (2009) (33)
Retinoblastoma protein purification and transduction of retina and retinoblastoma cells using improved alphavirus vectors. (2004) (33)
Transcriptional and Epigenetic Regulation of KIF14 Overexpression in Ovarian Cancer (2014) (33)
Predictive testing for retinoblastoma comes of age. (1997) (32)
Altered anterior visual system development following early monocular enucleation☆ (2013) (32)
Dual mechanisms of repression of E2F1 activity by the retinoblastoma gene product. (1996) (31)
A simplified scheme for genetic counseling in retinoblastoma. (1987) (31)
Human retinoblastoma is not caused by known pRb‐inactivating human DNA tumor viruses (2007) (30)
Global issues and opportunities for optimized retinoblastoma care (2007) (30)
Distinct patterns of expression of the RB gene family in mouse and human retina. (2005) (29)
Early unilateral enucleation disrupts motion processing (2002) (29)
The p75NTR neurotrophin receptor is a tumor suppressor in human and murine retinoblastoma development (2008) (28)
The B-Domain Lysine Patch of pRB Is Required for Binding to Large T Antigen and Release of E2F by Phosphorylation (2002) (26)
FGFR3 mutations, but not FGFR3 expression and FGFR3 copy-number variations, are associated with favourable non-muscle invasive bladder cancer (2014) (26)
Diagnosis and reversal of multidrug resistance in paediatric cancers. (1996) (25)
The TAg-RB murine retinoblastoma cell of origin has immunohistochemical features of differentiated Muller glia with progenitor properties. (2011) (25)
Pars Plana Vitrectomy and Endoresection of Refractory Intraocular Retinoblastoma. (2017) (25)
Retinoblastoma: a model of oncogenesis. (1984) (25)
Retinoblastoma gene mutations in human cancer. (1994) (25)
Visual results in children treated for macular retinoblastoma (2002) (25)
Clinical and genetic associations for carboplatin‐related ototoxicity in children treated for retinoblastoma: A retrospective noncomparative single‐institute experience (2018) (24)
Single-center retrospective study of the effectiveness and toxicity of the oral iron chelating drugs deferiprone and deferasirox (2019) (24)
Medical radiation exposure and risk of retinoblastoma resulting from new germline RB1 mutation (2011) (24)
Canadian guidelines for retinoblastoma care. (2009) (23)
Trilateral Retinoblastoma with Pituitary-Hypothalamic Dysfunction (2008) (23)
Ocular Genetics Program: multidisciplinary care of patients with ocular genetic eye disease. (2007) (23)
Re-evaluation of the sublocalization of esterase D and its relation to the retinoblastoma locus by in situ hybridization. (1987) (23)
The RB1 Story: Characterization and Cloning of the First Tumor Suppressor Gene (2019) (23)
Global Retinoblastoma Treatment Outcomes: Association with National Income Level. (2020) (22)
Toxocariasis mimicking liver, lung, and spinal cord metastases from retinoblastoma. (2009) (22)
A Multicenter, International Collaborative Study for American Joint Committee on Cancer Staging of Retinoblastoma (2020) (21)
Familial, EsD-linked, retinoblastoma with reduced penetrance and variable expressivity (2004) (21)
Focal stereotactic external beam radiotherapy as a vision-sparing method for the treatment of peripapillary and perimacular retinoblastoma: preliminary results. (2006) (21)
Ultrasound biomicroscopy in the management of retinoblastoma (2011) (21)
Patients presenting with metastases: stage IV uveal melanoma, an international study (2021) (21)
Achieving optimal cancer outcomes in East Africa through multidisciplinary partnership: a case study of the Kenyan National Retinoblastoma Strategy group (2016) (21)
Novel 6p rearrangements and recurrent translocation breakpoints in retinoblastoma cell lines identified by spectral karyotyping and mBAND analyses. (2007) (21)
Detection of optic nerve disease in retinoblastoma by use of spectral domain optical coherence tomography. (2012) (20)
Altered white matter structure in the visual system following early monocular enucleation (2018) (20)
Nuclear localization conferred by the pocket domain of the retinoblastoma gene product. (1999) (19)
Anterior diffuse retinoblastoma: mutational analysis and immunofluorescence staining. (2009) (19)
Retinoma associated with vitreous seeding. (1995) (19)
Using RB1 mutations to assess minimal residual disease in metastatic retinoblastoma. (2010) (19)
Socioeconomic and psychological impact of treatment for unilateral intraocular retinoblastoma. (2015) (19)
Multifaceted chemotherapy for trilateral retinoblastoma. (2011) (18)
Conjunctival melanoma treatment outcomes in 288 patients: a multicentre international data-sharing study (2020) (18)
Head turn in 1-eyed and normally sighted individuals during monocular viewing. (1997) (18)
A Multicenter, International Collaborative Study for AJCC-Staging of Retinoblastoma: Treatment Success and Globe Salvage. (2020) (18)
Why don't germline mutations in RB1 predispose to leukemia? (1992) (18)
Increased cortical surface area and gyrification following long-term survival from early monocular enucleation (2014) (17)
Nuclear E-cadherin and VHL immunoreactivity are prognostic indicators of clear-cell renal cell carcinoma (2008) (17)
Proceedings of the Association for Research in Vision and Ophthalmology and Champalimaud Foundation Ocular Oncogenesis and Oncology Conference (2019) (16)
Familial retinoblastoma: segregation of chromosome 13 in four families. (1980) (16)
Retinoma underlying retinoblastoma revealed after tumor response to 1 cycle of chemotherapy. (2009) (15)
Use of the RB1 cDNA as a diagnostic probe in retinoblastoma families (1990) (15)
Multiple manifestations of the retinoblastoma gene. (1982) (15)
Gene carrier detection in retinoblastoma. (1980) (15)
No ocular motility complications after subtenon topotecan with fibrin sealant for retinoblastoma. (2013) (15)
Identification of clinically relevant mosaicism in type I hereditary haemorrhagic telangiectasia (2011) (15)
Histocompatibility typing in spontaneous regression of retinoblastoma. (1977) (14)
Impact of Systemic Chemotherapy and Delayed Enucleation on Survival of Children with Advanced Intraocular Retinoblastoma. (2020) (14)
Needle core biopsies provide ample material for genomic and proteomic studies of kidney cancer: observations on DNA, RNA, protein extractions and VHL mutation detection. (2012) (14)
Evidence of multisensory plasticity: Asymmetrical medial geniculate body in people with one eye (2015) (14)
Optic Nerve Head Metastasis (1975) (13)
Screening for Pineal Trilateral Retinoblastoma Revisited: A Meta-analysis. (2019) (13)
Somatic events unmask recessive cancer genes to initiate malignancy (1986) (13)
Retinoblastoma versus advanced Coats’ disease: Is enucleation the answer? (2017) (13)
ACTIVE SURVEILLANCE OF SMALL RENAL MASSES: A PROSPECTIVE MULTI-CENTER CANADIAN URO-ONCOLOGY GROUP TRIAL (2009) (13)
Foveal and eccentric acuity in one-eyed observers (2002) (13)
A Multicenter, International Collaborative Study for AJCC-Staging of Retinoblastoma: Metastasis-Associated Mortality. (2020) (13)
How do retinoblastoma tumours form? (1992) (13)
Number 1 : Prospective Validation of a MultiGene Prognostic Assay in Uveal Melanoma (2012) (13)
A physical map around the retinoblastoma gene. (1990) (13)
Impaired speed perception but intact luminance contrast perception in people with one eye. (2013) (12)
Identification of a mutation in exon 27 of the RB1 gene associated with incomplete penetrance retinoblastoma (2008) (12)
Breaking down barriers to communicating complex retinoblastoma information: can graphics be the solution? (2015) (12)
SEGREGATION OF CHROMOSOME 13 IN RETINOBLASTOMA (1978) (12)
Unaffected smooth pursuit but impaired motion perception in monocularly enucleated observers (2014) (11)
Clinical Predictors at Diagnosis of Low-Risk Histopathology in Unilateral Advanced Retinoblastoma. (2019) (11)
Extraocular Muscle Proprioception and Visual Function: Psychophysical Aspects (1988) (11)
Clinical utility gene card for: Retinoblastoma (2011) (11)
Radiation sensitivity of fibroblasts of bilateral retinoblastoma patients as determined by micronucleus induction in vitro. (1985) (11)
Acute Macular Outer Retinopathy ( AMOR ) : A Reappraisal of Acute Macular Neuroretinopathy Using Multimodality Diagnostic Testing (2011) (10)
Prosthetic conformers: a step towards improved rehabilitation of enucleated children (2002) (10)
Incidental neuroblastoma with bilateral retinoblastoma: what are the chances? (2018) (10)
Multidrug resistance in cancers of childhood: clinical relevance and circumvention. (1993) (10)
Retinoblastoma with central retinal artery thrombosis that mimics extraocular disease. (2002) (10)
The role of KIF14 in patient-derived primary cultures of high-grade serous ovarian cancer cells (2014) (10)
Vision and visual potential for perifoveal retinoblastoma after optical coherence tomographic-guided sequential laser photocoagulation (2018) (9)
Molecular analysis distinguishes metastatic disease from second cancers in patients with retinoblastoma. (2016) (9)
Predilection of retinoblastoma metastases for the mandible. (2002) (9)
Precision laser therapy for retinoblastoma (2018) (9)
ACTIVE SURVEILLANCE OF SMALL RENAL MASSES: A PROSPECTIVE MULTI-CENTRE CANADIAN TRIAL (2008) (8)
Ocular penetration, toxicity, and radiosensitization effects of two hypoxic cell radiosensitizers on retinoblastoma. (1986) (8)
Psychosocial determinants for treatment decisions in familial retinoblastoma (2017) (8)
Retinoid-binding proteins in retinoblastoma tumors. (1988) (8)
Quantitative Analysis of Tumor Size in a Murine Model of Retinoblastoma (2009) (7)
A Language for Retinoblastoma: Guidelines and Standard Operating Procedures (2011) (7)
Late-diagnosis retinoblastoma with germline mosaicism in an 8-year-old. (2014) (7)
Natural History of Untreated Retinoblastoma (2021) (7)
Low incidence of deletion of the esterase D locus in retinoblastoma patients (2004) (7)
Which retinoblastoma patients should be screened for RB1 mutations? (1998) (7)
Horizontal saccade dynamics after childhood monocular enucleation. (2013) (6)
Leukocoria caused by intraocular heterotopic brain tissue. (2004) (6)
[Detection of RB1 mutations by using quantitative fluorescent mutiplex PCR]. (1999) (6)
Intraoperative use of ultrasound in the management of choroidal melanomas (1987) (6)
Genetics of Retinoblastoma and Genetic Counseling (2010) (6)
Adult ovarian retinoblastoma genomic profile distinct from prior childhood eye tumor. (2011) (6)
Absence of chromosome breakage in patients with retinoblastoma (1979) (6)
Common neuroectodermal antigens on human melanoma neuroblastoma, retinoblastoma, glioblastoma and fetal brain melanoma cells. Abstr. (1981) (6)
Molecular testing prognostic of low risk in epithelioid uveal melanoma in a child (2013) (5)
Response criteria for intraocular retinoblastoma: RB‐RECIST (2021) (5)
509: The Natural History of Small Renal Masses: A Prospective Multi-Center Canadian Trial (2007) (5)
Secondary Prevention of Retinoblastoma Revisited: Laser Photocoagulation of Invisible New Retinoblastoma. (2019) (5)
Hypersensitivity to sub-Tenon's topotecan in fibrin adhesive in patients with retinoblastoma. (2015) (5)
A retrospective review of visual outcome and complications in the treatment of retinoblastoma. (2005) (4)
Early monocular enucleation selectively disrupts neural development of face perception in the occipital face area. (2019) (4)
DNA hypermethylation/boundary control loss identified in retinoblastomas associated with genetic and epigenetic inactivation of the RB1 gene promoter (2020) (4)
Radiologic surveillance for retinoblastoma metastases unexpectedly showed disseminated toxocariasis in liver, lung, and spinal cord. (2010) (4)
Retinoblastoma: Importance of recessive mutations in tumorigenesis (1984) (4)
Retinoblastoma seeds: impact on American Joint Committee on Cancer clinical staging (2021) (4)
KIF 14 negatively regulates Rap 1 a – Radil signaling during breast cancer progression (4)
A novel deep intronic low penetrance RB1 variant in a retinoblastoma family (2018) (3)
Clinical audit of retinoblastoma management: a retrospective single-institution study. (2021) (3)
Consumer Digital Cameras: A Feasible Strategy for the Early Detection of Childhood Blindness (2012) (3)
Aseptic pediatric orbital cellulitis: retinoblastoma until otherwise proven (2019) (3)
Metastatic Death Based on Presenting Features and Treatment for Advanced Intraocular Retinoblastoma (2022) (3)
Egocentric localization: visually directed alignment to projected head landmarks in binocular and monocular observers. (1999) (3)
RB1 germline mutation spectrum and clinical features in patients with unilateral retinoblastomas (2021) (2)
Co-cultivation of retinoblastoma with fibroblasts, iris pigment epithelium, and retinal pigment epithelium in tissue culture. (1983) (2)
Measurement of cardiac output in rats by 125 I dilution. (1971) (2)
Clinicopathologic case reports: Optic nerve head metastasis. (1975) (2)
Retinoblastoma Survival Following Primary Enucleation by AJCC Staging (2021) (2)
Characterization of a stable, anchorage-dependent clone obtained from a spontaneously transformed mouse cell line (1984) (2)
Experience with plaque irradiation of choroidal melanomas (1986) (2)
The effect of persisting hypovolemic shock on pancreatic output of insulin. (1972) (2)
Cyclosporin-modulated chemotherapy with focal cryo/laser therapy: a new approach to retinoblastoma (1994) (2)
VHL-mutant renal cell carcinomas contain cancer cells with mesenchymal phenotypes. (2013) (2)
Retinoblastoma: The Prototypic Hereditary Tumor (2009) (2)
Unusual ocular presentation of von Hippel-Lindau disease. (2005) (2)
Advances in Brief Genomic Amplification in Retinoblastoma Narrowed to 0 . 6 Megabase on Chromosome 6 p Containing a Kinesin-like Gene , RBKIN 1 (2002) (2)
Intra-arterial Chemotherapy for Retinoblastoma-Reply. (2016) (2)
Unexploited potential of molecular technology to unravel the pathogenesis of ocular diseases. (1988) (2)
Primary laser therapy as monotherapy for discrete retinoblastoma (2021) (1)
[Low-penetrance retinoblastoma due to exons 24 and 25 deletions in the Rb1 gene]. (2002) (1)
Asynchronous pineoblastoma is more likely after early diagnosis of retinoblastoma: a meta‐analysis (2021) (1)
Applications of Iodine-125 Plaque Radiotherapy for Residual or Recurrent Retinoblastoma. (2021) (1)
Abstract 958: Improving survival of extraocular, metastatic and trilateral retinoblastoma patients with combined intensive therapy. (2013) (1)
Re: Metastatic deaths in retinoblastoma patients treated with intraarterial chemotherapy (ophthalmic artery chemosurgery) worldwide (2018) (1)
Radiation compromised survival of patients with heritable retinoblastoma (H1): what will be the long-term consequences of current eye salvage therapies? (2017) (1)
Tylectomy Safety in Salvage of Eyes with Retinoblastoma (2021) (1)
12 – Retinoblastoma Gene: Mutations, Expression, and Putative Function (1991) (1)
Correspondence on 'Intra-arterial chemotherapy for retinoblastoma: an updated systematic review and meta-analysis' by Ravindran et al (2022) (1)
White orbital mass after enucleation for retinoblastoma: The power of illusion (2017) (1)
Early monocular enucleation selectively disrupts the development of neural mechanisms for face perception (2014) (1)
Correction of the interstitial diffusion defect in hemorrhagic shock by balanced salt solution. (1971) (1)
Metachronous, non‐pineal, trilateral retinoblastoma in a patient with a seemingly reduced‐expressivity RB1 germline deletion (2022) (1)
Early life maturation of human visual system white matter is altered by monocular enucleation (2019) (1)
Genetics of the Pathophysiology of Retinoblastoma (2018) (1)
A new instrument for cryoenucleation (1984) (1)
Abstract 1333: Specific RB1 mutations and risk of subsequent neoplasms among survivors of hereditary retinoblastoma. (2013) (1)
Retinal mapping of heritable retinoblastoma (2019) (1)
High-risk Pathologic Features Based on Presenting Findings in Advanced Intraocular Retinoblastoma (2022) (1)
Mutations intheRBIGeneandTheir Effects on Transcription (1989) (1)
Genetics of Retinoblastoma for Patients and Their Families (2019) (1)
1. Ota KV, Dimaras H, Heon E, et al. Toxocariasis mimicking liver, lung, and spinal cord metastases from retinoblastoma. Pediatr Infect Dis J 2009;28:252-4. (2010) (1)
Can RB1 Mutation Analysis be Used to Predict Disease Expression in Patients With Heritable Retinoblastoma (2005) (1)
Abstract A186: KIF14 is a novel therapeutic target for ovarian cancer. (2011) (1)
Individualized iridium 192 wire molds for treatment of large accessible malignant melanomas of the choroid (1982) (1)
Heritable Retinoblastoma: Genotype–Phenotype Correlations (2004) (0)
CostComparison ofMolecular versusConventional Screening ofRelatives atRiskforRetinoblastoma (1996) (0)
Double dissociation in monocular blindness: Enhanced contrast but impaired motion perception (2010) (0)
Optical coherence tomography guided localization and laser photocoagulation of invisible new retinoblastoma (2019) (0)
Good long term results of multidrug resistance-reversal chemotherapy for advanced intraocular retinoblastoma without upfront elective consolidation radiation (2005) (0)
Psychosocial and economic impacts of treatment decisions for advanced unilateral intraocular retinoblastoma on Egyptian families (2014) (0)
Condensation of Prophase Chromosomes (2014) (0)
Genomic amplification in retinoblastoma narrowed to 1.2 Mb on chromosome 6p containing a novel kinesin-like gene, RBKIN (2001) (0)
293: A Novel Medical Informatics Tool for the Management of Patients with Bladder Cancer (2004) (0)
Abstract A68: Optical coherence tomography improves subclinical retinoblastoma management (2020) (0)
Abstract 694: Cyclosporin-modulated intensified dosage chemotherapy well-tolerated for saving eyes with intraocular retinoblastoma (2011) (0)
Reply. (1953) (0)
The Role of Deferiprone in Iron Chelation. (2019) (0)
Radiosensitizers in Retinoblastoma (1979) (0)
Pediatric Cataract Surgery Following Treatment for Retinoblastoma: A Case Series and Systematic Review. (2022) (0)
Probing the immunological side. (1977) (0)
A Cascade of Genomic Changes Leads to Retinoblastoma (2003) (0)
A White Retinal Lesion With Calcification in an 11-Year-Old Boy. (2022) (0)
Author response: Does the time of inactivation of pRb determine the cell of origin of retinoblastoma? (2012) (0)
Red reflex examination for retinoblastoma – Authors' reply (2012) (0)
Altered white matter structure within the visual pathway of children with early unilateral enucleation (2018) (0)
Optical coherence tomography guided precision management strategies for retinoblastoma (2019) (0)
AJCC-Staging for Retinoblastoma: One System for Both Globe Salvage and Patient Mortality (2020) (0)
Abstract 3771: Oncogenes and tumour-suppressors drive differential retinoblastoma evolution (2019) (0)
Figure 1. [Schematic of the molecular genetic...]. (2015) (0)
The Risk of Retinoblastoma (RB) and Cost of Screening Relatives of Probands (2006) (0)
Surgical ischemia and detection of clear cell renal cell carcinoma biomarkers. (2014) (0)
Abstract 1278: Determining the proteomic changes that define progressor and non-progressor clear cell renal cell carcinoma (2012) (0)
MG-127 Residual disease monitoring in a retinoblastoma patient by pcr of a novel deletion breakpoint (2015) (0)
Regulation of p14ARF expression by miR-24: a potential mechanism compromising the p53 response during retinoblastoma development (2012) (0)
Rigaud and Schmincke Types of Lymphoepithelioma (2011) (0)
INVITED EDITORIAL Predictive Testing for Retinoblastoma Comes of Age (2006) (0)
Retinoblastoma, Molecular Genetics of (2006) (0)
Reply. (2018) (0)
Early delivery of children with prenatal RB1 mutation identification at risk for retinoblastoma (2016) (0)
Reply to G. Chantada et al and B.S. Wallang et al (2011) (0)
Pilot Study Of The Feasibility And Efficacy Of RB1 Mutation Detection In India Using A Global-to-local Approach (2011) (0)
Past Lecturers and Briefs for the Named Lectures: RANZCO Annual Scientific Congress (2016) (0)
Nitric oxide suppression by secreted frizzled-related protein 2 drives retinoblastoma. (2023) (0)
The Retinoblastoma Research Booklet: A Catalyst for Patient Involvement in Retinoblastoma Research. (2022) (0)
Abstract 809: Prenatal and postnatal management of infants at 100%-risk for developing retinoblastoma (2012) (0)
Welfare of patients and clinicians: academic freedom is vital (2017) (0)
Predictive factors for Carboplatin related ototoxicity in children treated for Retinoblastoma (2016) (0)
Reply. (2018) (0)
Changes in functional activation for audiovisual stimuli in people with one eye (2017) (0)
Spatiotemporal evolution of germline retinoblastoma (2018) (0)
INVITEDEDITORIAL Predictive Testing forRetinoblastoma ComesofAge (1997) (0)
Retinoid-binding proteins in seven new retinoblastoma cell lines: a comparison with Y-79 (1986) (0)
Abstract 767: Cyclosporin-modulated intensified-dosage chemotherapy for saving eyes with Group D intraocular retinoblastoma (2014) (0)
Genetic Progression from Retina to Retinoblastoma (2008) (0)
A typical anterior retinoblastoma: diagnosis by aqueous humor cell-free DNA analysis (2022) (0)
Pediatric cataract surgery following treatment for retinoblastoma (2021) (0)
Abstract B63: Survivorship, vision, and eye salvage following pars plana vitrectomy for residual active or recurrent retinoblastoma (2020) (0)
Transcriptional repression of the E2-containing promoters EIIaE, c-myc, and RB1 by the product of the RB1 gene (1992) (0)
Past Lecturers and Briefs for the Named Lectures: RANZCO Annual Scientific Congress (2015) (0)
The Role of Hematoporphyrin in the Diagnosis and Treatment of Ocular Tumors (1981) (0)
International Intraocular Retinoblastoma Classification Correlates with Pathological pTNM Staging (2011) (0)
Abstract A63: Overcoming challenges in health care with machine learning: Innovation from retinoblastoma (2020) (0)
Genotype-phenotype Correlations in Heritable Retinoblastoma (2003) (0)
Pathobiologic Changes in Diffuse Anterior Retinoblastoma (2008) (0)
P-Glycoprotein Chemotherapy despite Cyclosporine for Reversal of Retinoblastoma Correlates with the Rare Failure of Multidrug Resistance Protein ( MRP ) Expression in Updated Version (2006) (0)
Table 1. [Molecular Genetic Testing Used in Heritable Retinoblastoma]. (2015) (0)
Table 3. [Empiric Risks for Development of...]. (2015) (0)
Exon 24-25 deletion of RB1 in a four-generation low-penetrance retinoblastoma family (1994) (0)
EMPOWER Retinoblastoma: Engaging Patient Partners in Solving the Top 10 Priorities for Eye Cancer Research in Canada. (2022) (0)
Point mutations in retinoblastoma. (1990) (0)
High-Risk Pathology Based on Presenting Features in Advanced Intraocular Retinoblastoma: A Multicenter, International Data-Sharing AJCC Study. (2022) (0)
1182 GROWTH KINETICS OF SMALL RENAL MASSES: A PROSPECTIVE ANALYSIS FROM THE RENAL CELL CARCINOMA CONSORTIUM OF CANADA (2013) (0)
RETINOBLASTOMA PROTEIN REGULATION OF HLA CLASS II GENE EXPRESSION (1993) (0)
Abstract 4361: Retinoblastoma (RB) genomic progression analysis using Tissue Microarrays (TMA) comprising 121 RB patient tumors (2010) (0)
Table 2. [Probability of a Germline Pathogenic...]. (2015) (0)
Author's response to reviews Title: miR-24 contributes to retinoblastoma development by compromising the p53 response to RB1 loss in retina Authors: Kwong-Him To (tim.to@utoronto.ca) (2011) (0)
White matter changes following early loss of one eye extend beyond the primary visual pathway (2017) (0)
Author's response to reviews Title: miR-24 contributes to retinoblastoma development by compromising the p53 response to RB1 loss in retina Authors: Kwong-Him To (tim.to@utoronto.ca) (2011) (0)
Abnormal cortical activation in response to motion in people who have lost one eye early in life (2010) (0)
Reduced LGN volume following early monocular deprivation from enucleation (2012) (0)
Eye Movements , Strabismus , Amblyopia , and Neuro-Ophthalmology Horizontal Saccade Dynamics After Childhood Monocular Enucleation (2013) (0)
Question: can you identify this condition? Answer: leukocoria. (2010) (0)
large-T-antigen-binding regions. outside the simian virus 40 gene product is determined by domains Hyperphosphorylation of the retinoblastoma (2013) (0)
Mitotic recombination in retinoblastoma (1984) (0)
005: A 20-year review of the management and outcome of unilateral retinoblastoma (2009) (0)
Comprehensive therapy for trilateral retinoblastoma (2008) (0)
Transmission of a High-Penetrance RB1 Gene Mutation From Parent to Offspring, Resulting in Low-Penetrance Mutation Due to Meiotic Recombination (2009) (0)
Author's response to reviews Title: miR-24 contributes to retinoblastoma development by compromising the p53 response to RB1 loss in retina Authors: Kwong-Him To (kwonghim@gmail.com) (2011) (0)
Author's response to reviews Title: miR-24 contributes to retinoblastoma development by compromising the p53 response to RB1 loss in retina Authors: Kwong-Him To (kwonghim@gmail.com) (2011) (0)
Retinoblastoma: patients, tumors, gene and protein contribute to the understanding of cancer (2001) (0)
Point Estimates of Number Needed to Treat/Screen Are Insufficient Without Characterization of Their Uncertainty (2011) (0)
Colorectal tumours examined for genetic changes at chromosomes 13 and 17 with special reference to the RB1 and TP53 genes (1992) (0)
Molecular RB1 gene detection of minimal residual disease in metastatic retinoblastoma (2006) (0)
Abstract 3535: Retinoblastoma cerebrospinal fluid metastases treatable by intensive intraventricular and multidrug resistance-reversal systemic chemotherapy without radiation (2010) (0)

This paper list is powered by the following services:

Other Resources About Brenda Gallie

What Schools Are Affiliated With Brenda Gallie?

Brenda Gallie is affiliated with the following schools: